Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 542.33 million as of April 29, 2026. Its market cap has increased by 26.90% in one year.

Market Cap

542.33M

Enterprise Value

609.31M

Revenue

71.12M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.31

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 542.33M, a decrease of -67.52%. That is a compound annual growth rate of -11.52%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	542.33M	-58.61%
Dec 30, 2025	1.31B	291.35%
Dec 30, 2024	334.83M	-53.79%
Dec 29, 2023	724.64M	-36.76%
Dec 30, 2022	1.15B	81.18%
Dec 30, 2021	632.45M	-94.51%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
FluoGuide	701.39M
Intervacc AB	411.70M
Corline Biomedical AB	409.82M
Ascelia Pharma AB	383.78M
Infant Bacterial Therapeutics AB	762.48M
Sprint Bioscience AB	328.15M
Bio-Works Technologies AB	314.18M
Mendus AB	311.04M

Market Cap Rankings